Supporting patients with metastatic breast cancer during therapy with cyclin-dependent kinase 4/6 (CDK) inhibitors: A needs assessment. This is an ASCO Meeting Abstract from the 2022 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results